Researchers examine survival and cancer recurrence in patients with glottic carcinomas receiving one of two treatments.

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.